ATRI’s work is built on a foundation of strong, openly shared data. In this episode, ATRI’s own Clinical Research Director Lindsey Hergesheimer joins the podcast to discuss her work, from starting at ATRI working in data management to transitioning to clinical monitoring. Lindsey shares an inside look at ATRI’s approach to clinical research and explains why clinical monitoring is such an important part of advancing Alzheimer’s treatment. Lindsey also opens up about her personal connection to the work she’s doing and describes how ATRI’s culture of continuous learning has helped her grow throughout her career.
Episode Recap:
- In this episode we’ll talk with ATRI’s Clinical Monitoring Director Lindsey Hergesheimer (0:40)
- What is clinical monitoring, and how did you get involved with it? (1:30)
- How does ATRI use deidentified data for clinical research? (4:15)
- How did COVID-19 impact your work in clinical monitoring? (11:28)
- What’s it like to be a clinical monitor visiting different sites? (18:37)
- What keeps you motivated to continue working in Alzheimer’s research? (23:14)
- Why is open data sharing so important at ATRI? (26:06)
- What advice would you give to people interested in this career path? (30:10)
- How do you stay grounded and maintain work-life balance? (33:37)
- What are your hopes for the future of ATRI and Alzheimer’s research? (36:17)
Learn more about ATRI
